Aurobindo Pharma USA Inc.
East Windsor, NJ Doing business as Aurobindo Pharma U S A Inc.
- UEI
- MU7KBS6E6L25
- CAGE
- 43VQ4
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
- East Windsor, NJ DN63NKTYLF33
-
- SAM.gov registration date
- Physical address
- 279 Princeton Hightstown Rd, East Windsor, NJ 08520, USA
- Website
- aurobindo.com
- Founded
- 1986
- Employees
- 10K-50K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Contract awards
Quick answers
Is Aurobindo Pharma USA Inc. registered in SAM.gov?
Yes. Aurobindo Pharma USA Inc.'s SAM.gov registration is active through December 22, 2026.
What is Aurobindo Pharma USA Inc.'s CAGE code?
Aurobindo Pharma USA Inc.'s CAGE code is 43VQ4, and its Unique Entity ID (UEI) is MU7KBS6E6L25.
Which contract vehicles does Aurobindo Pharma USA Inc. hold?
Aurobindo Pharma USA Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Aurobindo Pharma USA Inc.'s most recent federal award?
Aurobindo Pharma USA Inc.'s most recent federal contract award is Tamsulosin HCL 0.4MG cap (36C77019P0419), from Veterans Integrated Service Network 15 (VHA), on January 15, 2019.
On GovTribe
See Aurobindo Pharma USA Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors